Site-directed mutagenesis and proton NMR spectroscopy of an interdomain segment in the pyruvate dehydrogenase multienzyme complex of Escherichia coli

Biochemistry ◽  
1988 ◽  
Vol 27 (1) ◽  
pp. 289-296 ◽  
Author(s):  
Frieda L. Texter ◽  
Sheena E. Radford ◽  
Ernest D. Laue ◽  
Richard N. Perham ◽  
John S. Miles ◽  
...  

1982 ◽  
Vol 124 (1) ◽  
pp. 63-69 ◽  
Author(s):  
Harry W. DUCKWORTH ◽  
Rainer JAENICKE ◽  
Richard N. PERHAM ◽  
Andrew O. M. WILKIE ◽  
John T. FINCH ◽  
...  




1992 ◽  
Vol 267 (32) ◽  
pp. 22830-22836 ◽  
Author(s):  
K Ostanin ◽  
E.H. Harms ◽  
P.E. Stevis ◽  
R Kuciel ◽  
M.M. Zhou ◽  
...  


1994 ◽  
Vol 180 (6) ◽  
pp. 2147-2153 ◽  
Author(s):  
M Pizza ◽  
M R Fontana ◽  
M M Giuliani ◽  
M Domenighini ◽  
C Magagnoli ◽  
...  

Escherichia coli enterotoxin (LT) and the homologous cholera toxin (CT) are A-B toxins that cause travelers' diarrhea and cholera, respectively. So far, experimental live and killed vaccines against these diseases have been developed using only the nontoxic B portion of these toxins. The enzymatically active A subunit has not been used because it is responsible for the toxicity and it is reported to induce a negligible titer of toxin neutralizing antibodies. We used site-directed mutagenesis to inactivate the ADP-ribosyltransferase activity of the A subunit and obtained nontoxic derivatives of LT that elicited a good titer of neutralizing antibodies recognizing the A subunit. These LT mutants and equivalent mutants of CT may be used to improve live and killed vaccines against cholera and enterotoxinogenic E. coli.



Sign in / Sign up

Export Citation Format

Share Document